OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Races of small molecule clinical trials for the treatment of COVID‐19: An up‐to‐date comprehensive review
Suwen Hu, Songwei Jiang, Qi Xiang, et al.
Drug Development Research (2021) Vol. 83, Iss. 1, pp. 16-54
Open Access | Times Cited: 44

Showing 26-50 of 44 citing articles:

Modeling the dynamics of COVID-19 Epidemic with a reaction-diffusion framework: a case study from Thailand
Rahat Zarin, Usa Wannasingha Humphries
The European Physical Journal Plus (2024) Vol. 139, Iss. 12
Closed Access | Times Cited: 2

Theoretical studies, spectroscopic investigation, molecular docking, molecular dynamics and MMGBSA calculations with 2‐hydrazinoquinoline
Prabuddha Bhattacharya, Khamael M. Abualnaja, Saleem Javed
Journal of Molecular Structure (2022) Vol. 1274, pp. 134482-134482
Closed Access | Times Cited: 12

Use of Antiviral Agents and other Therapies for COVID-19
Mark A. T. Blaskovich, Anthony D. Verderosa
Seminars in Respiratory and Critical Care Medicine (2023) Vol. 44, Iss. 01, pp. 118-129
Closed Access | Times Cited: 6

Natural Products as Potential Therapeutic Agents for SARS-CoV-2: A Medicinal Chemistry Perspective
Varun Aggarwal, Ekta Bala, Pawan Kumar, et al.
Current Topics in Medicinal Chemistry (2023) Vol. 23, Iss. 17, pp. 1664-1698
Closed Access | Times Cited: 6

Current Insights and Molecular Docking Studies of the Drugs under Clinical Trial as RdRp Inhibitors in COVID-19 Treatment
Amita Verma, Pradeep Kumar, Irine Pauly, et al.
Current Pharmaceutical Design (2022) Vol. 28, Iss. 46, pp. 3677-3705
Closed Access | Times Cited: 9

Harnessing Pyroptosis for Lung Cancer Therapy: The Impact of NLRP3 Inflammasome Activation
Rajiv Dahiya, Vijaykumar Sutariya, Sheeba Varghese Gupta, et al.
Pathology - Research and Practice (2024) Vol. 260, pp. 155444-155444
Closed Access | Times Cited: 1

Small molecules targeting mitochondria as an innovative approach to cancer therapy
Omkar Kamble, Rana Chatterjee, K.G. Abishek, et al.
Cellular Signalling (2024) Vol. 124, pp. 111396-111396
Closed Access | Times Cited: 1

Synthesis, Urease Inhibition, Molecular Docking, and Optical Analysis of a Symmetrical Schiff Base and Its Selected Metal Complexes
Samuel Bonne, Muhammad Saleem, Muhammad Asif Hanif, et al.
Molecules (2024) Vol. 29, Iss. 20, pp. 4899-4899
Open Access | Times Cited: 1

Exploring green synthesis and characterization of ZIF-8 and recent developments in anti-infective applications
Muath Suliman, Farag M. A. Altalbawy, Mandeep Kaur, et al.
Inorganic Chemistry Communications (2024), pp. 113333-113333
Closed Access | Times Cited: 1

Reprogramming Tumor-Associated Macrophages: The Role of MEK-STAT3 Inhibition in Lung Cancer
Sushama Rawat, Ehssan Moglad, Muhammad Afzal, et al.
Pathology - Research and Practice (2024) Vol. 265, pp. 155748-155748
Closed Access | Times Cited: 1

Computer-Aided Screening for Potential Coronavirus 3-Chymotrypsin-like Protease (3CLpro) Inhibitory Peptides from Putative Hemp Seed Trypsinized Peptidome
Kansate Prasertsuk, Kasidit Prongfa, Piyapach Suttiwanich, et al.
Molecules (2022) Vol. 28, Iss. 1, pp. 50-50
Open Access | Times Cited: 8

Turn-On Fluorescence Probe for Cancer-Related γ-Glutamyltranspeptidase Detection
Muhammad Saleem, Muhammad Hanif, Samuel Bonne, et al.
Molecules (2024) Vol. 29, Iss. 19, pp. 4776-4776
Open Access

Clinical effectiveness of oral antivirals for non-hospitalized adult COVID-19 patients aged 18–60 years
Wan‐Hsuan Hsu, Bo-Wen Shiau, Ya‐Wen Tsai, et al.
Expert Review of Anti-infective Therapy (2024), pp. 1-9
Closed Access

CRBN‐PROTACs in Cancer Therapy: From Mechanistic Insights to Clinical Applications
Riya Thapa, Asif Ahmad Bhat, Gaurav Gupta, et al.
Chemical Biology & Drug Design (2024) Vol. 104, Iss. 5
Open Access

Inhibition mechanisms of α-glucosidase by eight catechins: Kinetic, molecular docking, and surface plasmon resonance analysis
Rui Zhang, Yihua Zhang, Yu Tian, et al.
International Journal of Biological Macromolecules (2024) Vol. 283, pp. 137365-137365
Closed Access

Synthesis and Design of New 1,3,4‐Oxadiazole Benzimidazole Hybrids as Potential Antibacterial Agents Against MRSA by Targeting FabI
Gowsia Akhter, Hinna Hamid, Bharti Dhawan, et al.
ChemistrySelect (2024) Vol. 9, Iss. 48
Closed Access

COVID-19 and flu diagnosis from short electrocardiogram images using a residual neural network
Nayeon Kwon, Dongwon Lee, Yong‐Hoon Yoon, et al.
Biomedical Signal Processing and Control (2024) Vol. 103, pp. 107408-107408
Open Access

The Use of Small-Molecule Compounds for Cell Adhesion and Migration in Regenerative Medicine
Juan Mitchell, Kevin W.‐H. Lo
Biomedicines (2023) Vol. 11, Iss. 9, pp. 2507-2507
Open Access | Times Cited: 1

Applications of chem-bioinformatic, chemometric and machine learning approaches for COVID-19 related research
Kunal Roy
Structural Chemistry (2022) Vol. 33, Iss. 5, pp. 1389-1390
Open Access | Times Cited: 1

Previous Page - Page 2

Scroll to top